1-4 of 4
Tomoko Hara
Close
Sort by
Journal Articles

Induction of HM1.24 peptide–specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma

Ali Jalili, Shuji Ozaki, Tomoko Hara, Hironobu Shibata, Toshihiro Hashimoto, Masahiro Abe, Yasuhiko Nishioka, Toshio Matsumoto
Journal: Blood
Blood (2005) 106 (10): 3538–3545.
https://doi.org/10.1182/blood-2005-04-1438
Published: 2005
Journal Articles

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2

Takashi Oshima, Masahiro Abe, Jin Asano, Tomoko Hara, Kenichi Kitazoe, Etsuko Sekimoto, Yoichi Tanaka, Hironobu Shibata, Toshihiro Hashimoto, Shuji Ozaki, Shinsuke Kido, Daisuke Inoue, Toshio Matsumoto
Journal: Blood
Blood (2005) 106 (9): 3160–3165.
https://doi.org/10.1182/blood-2004-12-4940
Published: 2005
Journal Articles

Myeloma Cells Suppress Osteoblast Differentiation by Secreting a Soluble Wnt Inhibitor, sFRP-2.

Takashi Oshima, MD, Masahiro Abe, MD, Jin Asano, MD, Tomoko Hara, MD, Kenichi Kitazoe, MD, Etsuko Sekimoto, MD, Yoichi Tanaka, MD, Hironobu Shibata, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Shinsuke Kido, MD, Daisuke Inoue, MD, Toshio Matsumoto, MD
Journal: Blood
Blood (2004) 104 (11): 2356.
https://doi.org/10.1182/blood.V104.11.2356.2356
Published: 2004
Journal Articles

Generation of HM1.24-Specific Cytotoxic T Lymphocytes from Peripheral Blood Stem Cell Harvests of Patients with Multiple Myeloma.

Ali Jalili, Shuji Ozaki, MD, Tomoko Hara, MD, Etsuko Sekimoto, MD, Yoichi Tanaka, MD, Takashi Ohshima, MD, Hironobu Shibata, MD, Toshihiro Hashimoto, MD, Masahiro Abe, MD, Yasuhiko Nishioka, MD, Toshio Matsumoto, MD
Journal: Blood
Blood (2004) 104 (11): 1487.
https://doi.org/10.1182/blood.V104.11.1487.1487
Published: 2004